AI Agents to win denied health insurance claims.
Public company, workplace, funding, and market signals
Updated Aug 2, 2026
Aegis Health Technology Corp. (Aegis, YC X25) is an early-stage San Francisco healthtech company building AI agents for healthcare revenue-cycle management. Its focused wedge is automating the insurance-denial appeal workflow so providers can identify, prioritize, draft, submit, and track appeals and recover otherwise-lost revenue. Aegis was founded by three Carnegie Mellon-affiliated founders and entered Y Combinator’s Spring 2025 batch. Public sources disagree on financing totals: LinkedIn reports $125K, while YC’s standard 2025 investment and PitchBook report $500K; these should not be treated as a reconciled total.
Primary product
AI denial-management and revenue-recovery platform: automated denial detection and prioritization, retrieval of supporting EHR/EOB records, policy-aware appeal generation, submission through payer portals/fax/clearinghouses, and appeal tracking and analytics.
Founded
2025
Headquarters
San Francisco, California, United States
Team size
1–10 (public profiles variously report approximately 3–7 employees)
Industry
31 jobs at Aegis
Hospitals and Health Care / Healthtech
Sub-industry
Healthcare revenue-cycle management, insurance-claims denial management, AI/SaaS
Offices
Business model
Stage
Seed / Y Combinator Spring 2025 (X25)
Latest round
Y Combinator accelerator / seed investment · Apr 2025
Latest amount
$500K
Seed round — LinkedIn-reported figure
May 2025 · Y Combinator
Apr 2025 · Y Combinator
Y Combinator accelerator / seed investment
Apr 2025 · Y Combinator
Feb 2025
Investors
Public hiring and founder materials suggest a very small, founder-led, fast-moving engineering culture: close work with the founding team, rapid production shipping, independent debugging, and emphasis on healthcare impact. No formal benefits package was publicly documented.
Compensation
A May 2026 Applied AI Engineering Intern listing reported $5,000–$8,000 per month. No broader salary bands, equity terms, or benefits were publicly verified.
Pricing
Not publicly disclosed; appears to be enterprise B2B SaaS sold through demos and onboarding, with possible revenue-recovery/value-based economics not confirmed publicly.
Differentiators
Technology
Customers
Estimated revenue
Approximately $400K–$500K annual revenue/ARR, based on GetLatka’s $440K 2025 estimate and other third-party estimates; not company-audited.
Estimated monthly visits
3.6K
YesPress · Jul 2026
Profiled Aegis’s denial-detection, appeal-generation, payer-submission, and tracking workflow; reported approximately four employees, Epic/Athenahealth/eClinicalWorks integrations, HIPAA/SOC 2-oriented infrastructure, and reported backers.
Startuply.vc · May 2026
Discussed Aegis’s seed-stage positioning, end-to-end denial appeals product, reported 2025 revenue of $440K, and integration/compliance challenges.
Forbes Tech Council · Aug 2025
Forbes Tech Council article discussing the healthcare billing opportunity and featuring Aegis.
Forbes Tech Council · Aug 2025
Forbes Tech Council article featuring Aegis and its healthcare AI approach.
Business Insider · Jun 2025
Included Aegis among YC Spring 2025 agentic-AI startups and identified its three San Francisco founders; noted YC’s standard $500K investment.